Prevention and Therapeutic Strategies of Thromboembolic Events in Patients with Inflammatory Bowel Diseases: A Report of Three Cases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|3|194-198

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.3, 2015-03, pp. : 194-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases

By  

Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. : 303-306

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Strategies for the Blockade of IL-18 in Inflammatory Bowel Diseases

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1392-1399

Bentham Science Publishers

Access to resources Recommend Favorite

Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients: A Pharmacoeconomic Analysis

By Dranitsaris George  

PharmacoEconomics, Vol. 24, Iss. 6, 2006-01 ,pp. : 593-607

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients

By George Dranitsaris  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

By L.P.L. Gilissen  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 479-486

Adis International

Access to resources Recommend Favorite